GUSELKUMAB PARENTERAL LIQUID 100 MG/ML BOX OF PRE-FILLED SYRINGES/PENS

This tender, identified by process code RE-PU-CMFIEDM-2025-009-748941, concerns the procurement of Guselkumab parenteral liquid, specifically at a concentration of 100 mg/ml, supplied in boxes of pre-filled syringes or pens. The primary item required is Guselkumab, with a quantity of 15 units, valued at USD 1,563.15 per unit. The contracting entity is the CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES, DIALISIS LA MARISCAL. The procurement modality is classified as 'Unique Goods and Services,' indicating a specialized or potentially sole-source acquisition. Eligibility criteria for bidders include meeting 'Other Qualification Parameters,' ensuring 'Compliance with Specifications,' and providing a 'Technical Guarantee.' This suggests a rigorous selection process focused on the technical capabilities and product quality of the suppliers. The tender is aimed at securing a specific pharmaceutical product essential for patient treatment within the specified medical center, emphasizing the need for reliable and compliant suppliers in the healthcare sector. Further details regarding the specific technical specifications and the exact nature of the 'Other Qualification Parameters' would be crucial for interested parties to assess their eligibility and prepare a compliant bid.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 1,563 – USD 23,447.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.